Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanisms

Molecular Carcinogenesis

Volumn 51, Issue 1, 2012, Pages 53-63

  Bracci, Paige M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Body mass index; Etiology; Risk factor

Indexed keywords

ADIPONECTIN; ANTIINFLAMMATORY AGENT; AROMATIC HYDROCARBON; C PEPTIDE; HETEROCYCLIC AMINE; INSULIN; INTERLEUKIN 6; LEPTIN; LIVER RECEPTOR HOMOLOG 1; NITROSO DERIVATIVE; SOMATOMEDIN; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BODY MASS; CACHEXIA; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CELL PROLIFERATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA REPAIR; HUMAN; INSULIN BLOOD LEVEL; OBESITY; PANCREAS CANCER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; UNITED STATES; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGE FACTORS; BODY MASS INDEX; FEMALE; HUMANS; MALE; OBESITY; PANCREATIC NEOPLASMS; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 83455198203     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20778     Document Type: Article

References (64)

1. Altekruse S, Kosary C, Krapcho M. et al. SEER cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA 2010; 60: 277-300.
3. World Cancer Research Fund A. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington, DC: American Institute for Cancer Research; 2007.
4. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241. Epub: 2010 Jan, 2013.
5. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114-1117.
6. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009; 41: 986-990. Epub: 2009 Aug, 2002.
7. Petersen GM, Amundadottir L, Fuchs CS, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010; 42: 224-228. Epub: 2010 Jan, 2024.
8. Fearon KC, Baracos VE. Cachexia in pancreatic cancer: New treatment options and measures of success. HPB 2010; 12: 323-324.
9. Bueno de Mesquita HB, Moerman CJ, Runia S, Maisonneuve P. Are energy and energy-providing nutrients related to exocrine carcinoma of the pancreas? Int J Cancer 1990; 46: 435-444.
10. Calle EE, Rodriguez C, Jacobs EJ, et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics. Cancer 2002; 94: 2490-2501.
11. Eberle CA, Bracci PM, Holly EA. Anthropometric factors and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control 2005; 16: 1235-1244.
12. Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer 1991; 47: 1-6.
13. Hanley AJ, Johnson KC, Villeneuve PJ, Mao Y. Physical activity, anthropometric factors and risk of pancreatic cancer: Results from the Canadian enhanced cancer surveillance system. Int J Cancer 2001; 94: 140-147.
14. Howe GR, Jain M, Miller AB. Dietary factors and risk of pancreatic cancer: Results of a Canadian population-based case-control study. Int J Cancer 1990; 45: 604-608.
15. Larsson SC, Permert J, Hakansson N, Naslund I, Bergkvist L, Wolk A. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 2005; 93: 1310-1315.
16. Li D, Morris JS, Liu J, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009; 301: 2553-2562.
17. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286: 921-929.
18. Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN. Body mass index and physical activity as risk factors for pancreatic cancer: The Multiethnic Cohort Study. Cancer Causes Control 2007; 18: 165-175. Epub: 2007 Jan, 2011.
19. Silverman DT, Swanson CA, Gridley G, et al. Dietary and nutritional factors and pancreatic cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1998; 90: 1710-1719.
20. Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass index, and pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 2010; 170: 791-802.
21. Genkinger JM, Spiegelman D, Anderson KE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 2010 Nov 23. [Epub ahead of print].
22. Jiao L, Berrington de Gonzalez A, Hartge P, et al. Body mass index, effect modifiers, and risk of pancreatic cancer: A pooled study of seven prospective cohorts. Cancer Causes Control 2010; 21: 1305-1314.
23. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003; 89: 519-523.
24. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int J Cancer 2007; 120: 1993-1998.
25. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
26. Keith SW, Fontaine KR, Pajewski NM, Mehta T, Allison DB. Use of self-reported height and weight biases the body mass index-mortality association. Int J Obes (Lond) 2011; 35: 401-408.
27. Berrington de Gonzalez A, Spencer EA, Bueno-de-Mesquita HB, et al. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006; 15: 879-885.
28. Balentine CJ, Enriquez J, Fisher W, et al. Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 2010; 14: 1832-1837.
29. Benns M, Woodall C, Scoggins C, McMasters K, Martin R. The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol 2009; 16: 2565-2569. Epub: 2009 Jun, 2526.
30. Fleming JB, Gonzalez RJ, Petzel MQ, et al. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 2009; 144: 216-221.
31. Khan S, Sclabas G, Reid-Lombardo K, et al. Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma? J Gastrointest Surg 2010; 14: 1820-1825.
32. Tsai S, Choti MA, Assumpcao L, et al. Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: A large single-institution study. J Gastrointest Surg 2010; 14: 1143-1150.
33. McWilliams RR, Matsumoto ME, Burch PA, et al. Obesity adversely affects survival in pancreatic cancer patients. Cancer 2010; 116: 5054-5062.
34. Olson SH, Chou JF, Ludwig E, et al. Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 2010; 127: 2412-2419.
35. Batty GD, Kivimaki M, Morrison D, et al. Risk factors for pancreatic cancer mortality: Extended follow-up of the original Whitehall Study. Cancer Epidemiol Biomarkers Prev 2009; 18: 673-675. Epub: 2009 Feb, 2003.
36. Lee IM, Sesso HD, Oguma Y, Paffenbarger RS Jr. Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer 2003; 88: 679-683.
37. Nakamura K, Nagata C, Wada K, et al. Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: A prospective cohort study in Japan. Jpn J Clin Oncol 2010; 2010: 12.
38. Stevens RJ, Roddam AW, Spencer EA, et al. Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer 2009; 124: 2400-2405.
39. Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000; 11: 915-923.
40. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
41. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000; 283: 2552-2558.
42. Ansary-Moghaddam A, Huxley R, Barzi F, et al. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 2006; 15: 2435-2440.
43. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 2008; 114: 63-70.
44. Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer 2010; 19: 2298-2306. Epub: 2010 Aug, 2210.
45. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: New perspectives. ANNU 2010; 61: 301-316.
46. Berger N, editor. Cancer and energy balance, epidemiology and overview. New York, NY: Springer; 2010. p. 312.
47. Zyromski NJ, Mathur A, Pitt HA, et al. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 2009; 146: 258-263.
48. Stolzenberg-Solomon RZ, Weinstein S, Pollak M, et al. Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol 2008; 168: 1047-1055. Epub: 2008 Sep, 1018.
49. Chang MC, Chang YT, Su TC, et al. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis. Pancreas 2007; 35: 16-21.
50. Dalamaga M, Migdalis I, Fargnoli JL, et al. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: A case-control study. Cancer Causes Control 2009; 20: 625-633. Epub: 2008 Dec, 2003.
51. Krechler T, Zeman M, Vecka M, et al. Leptin and adiponectin in pancreatic cancer: Connection with diabetes mellitus. Neoplasma 2011; 58: 58-64.
52. Fantuzzi G. Adiponectin and inflammation: Consensus and controversy. J Allergy Clin Immunol 2008; 121: 326-330. Epub: 2007 Dec, 2003.
53. Loebig M, Klement J, Schmoller A, et al. Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men. PLoS One 2010; 5: e12610.
54. Ericson U, Wirfalt E, Mattisson I, Gullberg B, Skog K. Dietary intake of heterocyclic amines in relation to socio-economic, lifestyle and other dietary factors: Estimates in a Swedish population. Public Health Nutr 2007; 10: 616-627. Epub: 2007 Mar, 2023.
55. Rundle A, Madsen A, Orjuela M, et al. The association between benzo[a]pyrene-DNA adducts and body mass index, calorie intake and physical activity. Biomarkers 2007; 12: 123-132.
56. Ferguson LR. Natural and human-made mutagens and carcinogens in the human diet. Toxicology 2002; 181-182: 79-82.
57. Anderson KE, Kadlubar FF, Kulldorff M, et al. Dietary intake of heterocyclic amines and benzo(a)pyrene: Associations with pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2261-2265.
58. Li D, Day RS, Bondy ML, et al. Dietary mutagen exposure and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 655-661.
59. Anderson KE, Sinha R, Kulldorff M, et al. Meat intake and cooking techniques: Associations with pancreatic cancer. Mutat Res 2002; 506-507: 225-231.
60. Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, et al. Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 2664-2675.
61. Zhu J, Rashid A, Cleary K, et al. Detection of 2-amino-1-methyl-6-phenylimidazo [4, 5-b]-pyridine (PhIP)-DNA adducts in human pancreatic tissues. Biomarkers 2006; 11: 319-328.
62. Zhang J, Dhakal IB, Gross MD, et al. Physical activity, diet, and pancreatic cancer: A population-based, case-control study in Minnesota. Nutr Cancer 2009; 61: 457-465.
63. Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD. Physical activity and cancer prevention: Pathways and targets for intervention. Sports Med 2008; 38: 271-296.
64. O'Rorke MA, Cantwell MM, Cardwell CR, Mulholland HG, Murray LJ. Can physical activity modulate pancreatic cancer risk? A systematic review and meta-analysis. INT 2010; 126: 2957-2968.